The global demand for Genomics Personalized Health Market is presumed to reach the market size of nearly USD 87.41 Billion by 2032 from USD 56.78 Billion in 2023 with a CAGR of 4.91% under the study period 2024-2032.
Genomic personalized health is a unique approach to healthcare in which a patient's medical treatment is modified based on genetic information. A more sophisticated system has evolved from a better understanding of the human genome and ways for physicians to use that information in their patients' medical and surgical management. These can aid in diagnosing a wide range of complex disorders and lead to the development of more customized treatments based on genetic profiling, removing some conventional medications that may fail or have adverse side effects in a specific patient population. The research focuses on the design, development, and use of genomic discovery, analysis, and translation methodologies to promote genomics-driven healthcare and improve clinical and personalized health outcomes. Personalized medicine is a new field that uses a person's genetic profile to help guide decisions about illness prevention, diagnosis, and treatment. Doctors can use a patient's genetic profile to assist them in choosing the proper medication or therapy for them and administer it at the correct dose or regimen.
The global genomics personalized health market is driven by rising spending on research and development activities tied to biomarkers. Demand for genomics-based personalized health is expected to increase as chronic diseases like cancer and diabetes become more prevalent. The pharmaceutical sector's expansion and the assessment and prediction of treatment response are projected to propel the industry forward. Furthermore, the personalized genomics health market is affected by the booming molecular biology sector and technological advancements in the healthcare sector. Again, the growing elderly population has increased the prevalence of several chronic diseases, boosting the market's growth. Increased investment by diagnostic health care and governments is expected to be a critical driver of the genomics personalized health market's growth. However, the market expansion is hampered by a lack of awareness in emerging nations, time-consuming regulatory rules, data security and regulatory concerns, and significant data management issues.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genomics Personalized Health. The growth and trends of Genomics Personalized Health industry provide a holistic approach to this study.
This section of the Genomics Personalized Health market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
By Test
By End-User
This section covers the regional outlook, which accentuates current and future demand for the Genomics Personalized Health market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genomics Personalized Health market include Illumine, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Lonza Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1. PREFACE
1.1. Report Description
1.1.1 Objective
1.1.2 Target Audience
1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1 Market Research Process
1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3. GENOMICS PERSONALIZED HEALTH – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Technology
3.7.2 Market Attractiveness Analysis By Test
3.7.3 Market Attractiveness Analysis By End-User
3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY TECHNOLOGY
5.1. Overview By Technology
5.2. Historical and Forecast Data Analysis By Technology
5.3. NGS Platforms Historic and Forecast Sales By Regions
5.4. RT-PCR Historic and Forecast Sales By Regions
5.5. Microarray Historic and Forecast Sales By Regions
5.6. Genetic Analyzers Historic and Forecast Sales By Regions
6. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY TEST
6.1. Overview By Test
6.2. Historical and Forecast Data Analysis By Test
6.3. Oncology Testing Historic and Forecast Sales By Regions
6.4. Infectious Disease Testing Historic and Forecast Sales By Regions
6.5. Autoimmune Disease Testing Historic and Forecast Sales By Regio...
